4th Quarter - Report
WINNING STRATEGIES WASHINGTON for NOVARTIS
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1505 Affordable Biologics for Consumers Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Copyright/Patent/Trademark CPT
H.R. 1908; S. 1145-Patent Reform Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.